Recall Register

Food, drugs, devices › Nihon Kohden America Inc

Device recall: MEE-1000A Neuromaster, Model No. Accessories: MS-110B (Electric Stimulation), MS-120BK (Current Stimulator Box) JB-116B,

FDA enforcement event 73114 · Class II · initiated 19 Jan 2012 · status Terminated · terminated 22 Feb 2016

DeviceVoluntary: Firm initiated1 product recordIrvine, CA

FDA enforcement event 73114 is a device recall by Nihon Kohden America Inc of Irvine, CA, initiated 19 Jan 2012 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 88% of the 823 device enforcement events initiated in 2012 carry the same class.

Status: Terminated, terminated 22 Feb 2016. Initiation: voluntary: firm initiated. Nihon Kohden America Inc has 9 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Nihon Kohden America Inc, Irvine, CA.

Reason for recall

"The MEE-1000A Neuromaster had defective printed circuit boards (PCBs). Gas arrestors on these boards which were intended to provide protection from electrostatic discharge failed to prohibit unintentional current flow."

Distribution

"Worldwide distribution. US nationwide, Australia, Austria, France, Germany, Greece, Japan, Romania, South Africa, South Korea, Spain, and United Kingdom."

Product records

Recall numberProductQuantityClassStatusReport date
Z-0817-2016MEE-1000A Neuromaster, Model No. Accessories: MS-110B (Electric Stimulation), MS-120BK (Current Stimulator Box) JB-116B, JB-132B (Amplifiers) Electromyography. (EMG)477 units total (137 units in US)Class IITerminated24 Feb 2016

Context

88%of 2012 device events are Class II823 events that year
1product record in this eventfirm median: 1
9events on this register for the firm

Other enforcement events for Nihon Kohden America Inc

InitiatedProduct (first record)TypeClassRecords
18 Sep 2024Nihon Kohden Adult/Pediatric Forehead Disposable SpO2 Sensor, 0.9m Model 809030006 Disp. SpO2 Forehead Probe, Adult, 10/DeviceClass II2
29 Apr 2024BSM-3000 Series Bedside Monitor REF BSM-3572A The Life Scope BSM-3000 Series Bedside Monitoring System is intended to moDeviceClass II1
29 Apr 2022Adult Cap-ONE Biteblock REF YG-227T The cap-ONE Biteblock is intended to sample CO2 and administer supplemental oxygen, DeviceClass II1
8 Jan 2021WMTS Telemetry Receiver, Multiple Patient Receiver, Model Number/ UDI: ORG 9100A/ 00841983102554 ORG 9110A/ 008419831025DeviceClass II1
21 Dec 2020PSG-1100 Sleep Diagnostic System. Sample product label: JB-110A SERIAL No. 01454 RoHS Compliant; PSG-100 Head Box; UDI (DeviceClass II1
13 Mar 2017Bedside monitor CSM-1901(Life Scope G9) with main unit CU-192RA. The Problem only affects CSM-1901(Life Scope G9) communDeviceClass II1
14 Apr 2015Remote Network Station, Catalog RNS-9703, Model No. RNS-9703-19, RNS-9703-24, Software version 02.40. The RNS 9703 is inDeviceClass II1
3 Jun 2014CNS-6200 Series Central Nurse Station and accessories. Model Number: CNS-6201 For cardiac and vital signs monitoring forDeviceClass II1

All 9 events for Nihon Kohden America Inc

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "The MEE-1000A Neuromaster had defective printed circuit boards (PCBs). Gas arrestors on these boards which were intended to provide protection from electrostatic discharge failed to prohibit unintentional current flow."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide distribution. US nationwide, Australia, Austria, France, Germany, Greece, Japan, Romania, South Africa, South Korea, Spain, and United Kingdom."

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 22 Feb 2016. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.